Early symptoms and sensations as predictors of lung cancer: a machine learning multivariate model.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
11 11 2019
11 11 2019
Historique:
received:
12
05
2019
accepted:
23
10
2019
entrez:
13
11
2019
pubmed:
13
11
2019
medline:
5
11
2020
Statut:
epublish
Résumé
The aim of this study was to identify a combination of early predictive symptoms/sensations attributable to primary lung cancer (LC). An interactive e-questionnaire comprised of pre-diagnostic descriptors of first symptoms/sensations was administered to patients referred for suspected LC. Respondents were included in the present analysis only if they later received a primary LC diagnosis or had no cancer; and inclusion of each descriptor required ≥4 observations. Fully-completed data from 506/670 individuals later diagnosed with primary LC (n = 311) or no cancer (n = 195) were modelled with orthogonal projections to latent structures (OPLS). After analysing 145/285 descriptors, meeting inclusion criteria, through randomised seven-fold cross-validation (six-fold training set: n = 433; test set: n = 73), 63 provided best LC prediction. The most-significant LC-positive descriptors included a cough that varied over the day, back pain/aches/discomfort, early satiety, appetite loss, and having less strength. Upon combining the descriptors with the background variables current smoking, a cold/flu or pneumonia within the past two years, female sex, older age, a history of COPD (positive LC-association); antibiotics within the past two years, and a history of pneumonia (negative LC-association); the resulting 70-variable model had accurate cross-validated test set performance: area under the ROC curve = 0.767 (descriptors only: 0.736/background predictors only: 0.652), sensitivity = 84.8% (73.9/76.1%, respectively), specificity = 55.6% (66.7/51.9%, respectively). In conclusion, accurate prediction of LC was found through 63 early symptoms/sensations and seven background factors. Further research and precision in this model may lead to a tool for referral and LC diagnostic decision-making.
Identifiants
pubmed: 31712735
doi: 10.1038/s41598-019-52915-x
pii: 10.1038/s41598-019-52915-x
pmc: PMC6848139
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
16504Références
Thorax. 2005 Dec;60(12):1059-65
pubmed: 16227326
Lung Cancer. 2002 Apr;36(1):9-14
pubmed: 11891027
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
J Natl Cancer Inst. 2007 May 2;99(9):715-26
pubmed: 17470739
PLoS One. 2018 Nov 21;13(11):e0207686
pubmed: 30462699
Thorax. 2005 Apr;60(4):314-9
pubmed: 15790987
Soc Sci Med. 2006 Mar;62(6):1381-91
pubmed: 16168544
N Engl J Med. 2009 Dec 3;361(23):2221-9
pubmed: 19955524
BMJ Open. 2012 Nov 19;2(6):
pubmed: 23166137
BMJ. 2007 May 19;334(7602):1040
pubmed: 17493982
Cancer Imaging. 2011 Oct 03;11 Spec No A:S79-84
pubmed: 22185865
Br J Gen Pract. 2011 Nov;61(592):e715-23
pubmed: 22054335
Br J Gen Pract. 2013 Jan;63(606):e37-46
pubmed: 23336459
Br J Cancer. 2008 Jan 29;98(2):270-6
pubmed: 18087271
N Engl J Med. 2011 Aug 4;365(5):395-409
pubmed: 21714641
Thorax. 2013 May;68(5):451-9
pubmed: 23321602
Chest. 2013 May;143(5 Suppl):e1S-e29S
pubmed: 23649439
Mol Biosyst. 2015 Jan;11(1):13-9
pubmed: 25382277
Eur J Cancer Care (Engl). 2017 May;26(3):
pubmed: 28497588
JAMA Oncol. 2018 Oct 1;4(10):e182078
pubmed: 30003238
Lancet Oncol. 2017 Dec;18(12):e754-e766
pubmed: 29208441
Prev Med. 2002 Apr;34(4):436-44
pubmed: 11914050
Br J Cancer. 2015 Mar 31;112 Suppl 1:S6-13
pubmed: 25734397
Mayo Clin Proc. 2008 May;83(5):584-94
pubmed: 18452692